Neurizon Therapeutics Ltd
ASX:NUZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Neurizon Therapeutics Ltd
ASX:NUZ
|
AU |
|
Guotai Junan International Holdings Ltd
F:GUE
|
HK |
|
T
|
TCJ Asia PCL
SET:TCJ
|
TH |
|
P
|
Parker-Hannifin Corp
XMUN:PAR
|
US |
|
I
|
Immsi SpA
MIL:IMS
|
IT |
|
Z
|
Zen Corporation Group PCL
SET:ZEN
|
TH |
|
F
|
First Capital Equities Limted
KAR:FCEL
|
PK |
|
Australian Vintage Ltd
ASX:AVG
|
AU |
|
C
|
Chai Watana Tannery Group PCL
SET:CWT
|
TH |
|
I
|
Index International Group PCL
SET:IND
|
TH |
|
P
|
Premier Foods PLC
XMUN:FOJ1
|
UK |
|
U
|
Unique Mining Services PCL
SET:UMS
|
TH |
|
J
|
JCDecaux SE
XMUN:DCS
|
FR |
|
G
|
Global Green Chemicals PCL
SET:GGC
|
TH |
Shareholder Yield
Current shareholder yield for NUZ is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
NUZ Price
Neurizon Therapeutics Ltd
| Average Annual Return | -22.65% |
| Standard Deviation of Annual Returns | 38.69% |
| Max Drawdown | -77% |
| Market Capitalization | 68m AUD |
| Shares Outstanding | 775 100 000 |
| Percentage of Shares Shorted |
N/A
|
